One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Implementation of High-Sensitivity Cardiac Troponin Assays in the United States
Cian McCarthy, MB, BC H, BAO, a Shuang Li, MS, b Tracy Y. Wang, MD, MHS, MS, b,c Inbar Raber, MD,d Yader Sandoval, MD, e Nathaniel R. Smilowitz, MD, MS, f Jason H. Wasfy, MD, MP HIL,a Ambarish Pandey, MD,g James A. de Lemos, MD,g Michael C. Kontos, MD,h Fred S. Apple, PH D, i,j Lori B. Daniels, MD, MAS, k L. Kristin Newby, MD, MHS, b,c Allan S. Jaffe, MD, l,m James L. Januzzi, J R, MD
doi : 10.1016/j.jacc.2022.10.017
Volume 81, Issue 3, 24 January 2023, Pages 207-219
Few data exist regarding the implementation of high-sensitivity cardiac troponin (hs-cTn) assays in the United States since their approval.
High-Sensitivity Cardiac Troponin Assays in U.S. Hospitals: A Report Card
Martha Gulati, MD, MS,a David D. Berg, MD, MPH
doi : 10.1016/j.jacc.2022.11.015
Volume 81, Issue 3, 24 January 2023, Pages 220-223
PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection
Eliano P. Navarese, MD, PHD, a,b,c Przemysław Podhajski, MD,a,c Paul A. Gurbel, MD,d Klaudyna Grzelakowska, MD,a,c Eleonora Ruscio, MD,e Udaya Tantry, PHD, d Przemysław Magielski, MD,a Aldona Kubica, P HD, f Piotr Niezgoda, MD, a Piotr Adamski, MD, PHD, a Roman Junik, MD,g Grzegorz Przybylski, MD, h Marta Pilaczynska-Cemel, PHD, h Manali Rupji, MS, i Giuseppe Specchia, MD,j Jarosław Pinkas, MD, k Robert Gajda, MD, l Diana A. Gorog, MD,m,n Felicita Andreotti, MD, PHD, e,o,p Jacek Kubica, MD, PHD
doi : 10.1016/j.jacc.2022.10.030
Volume 81, Issue 3, 24 January 2023, Pages 224-234
The intensity of inflammation during COVID-19 is related to adverse outcomes. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in low-density lipoprotein receptor homeostasis, with potential influence on vascular inflammation and on COVID-19 inflammatory response.
PCSK9: The Nexus of Lipoprotein Metabolism and Inflammation in COVID-19
Sascha N. Goonewardena, MD,a Robert S. Rosenson, MD
doi : 10.1016/j.jacc.2022.11.014
Volume 81, Issue 3, 24 January 2023, Pages 235-236
Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients With Femoropopliteal Arterial Disease
Mehdi H. Shishehbor, DO, MPH, PH D, a Dierk Scheinert, MD,b Ashit Jain, MD,c Marianne Brodmann, MD,d Gunnar Tepe, MD,e Kenji Ando, MD, f Prakash Krishnan, MD,g Osamu Iida, MD, h John R. Laird, MD,i Peter A. Schneider, MD, j Krishna J. Rocha-Singh, MD, k Thomas Zeller, MD, PHD
doi : 10.1016/j.jacc.2022.10.016
Volume 81, Issue 3, 24 January 2023, Pages 237-249
Endovascular treatment of femoropopliteal artery disease has shifted toward drug-coated balloons (DCB). However, limited data are available regarding the safety and efficacy of DCB vs bare-metal stents (BMS).
Drug-Coated Balloons in Peripheral Vascular Interventions: Leave No Trace and Walk Away?
Dmitriy N. Feldman, MD,a Andrew J.P. Klein, MD
doi : 10.1016/j.jacc.2022.11.012
Volume 81, Issue 3, 24 January 2023, Pages 250-252
Declining Incidence of Postoperative Neonatal Brain Injury in Congenital Heart Disease
Shabnam Peyvandi, MD, MAS, a Duan Xu, PH D, b A. James Barkovich, MD, b Dawn Gano, MD, MAS, c Vann Chau, MD, d V. Mohan Reddy, MD,e Thiviya Selvanathan, MD, d Ting Guo, PH D, d J. William Gaynor, MD,f Mike Seed, MD, g Steven P. Miller, MBBS, MAS, h Patrick McQuillen, MD
doi : 10.1016/j.jacc.2022.10.029
Volume 81, Issue 3, 24 January 2023, Pages 253-266
Brain injury is common in neonates with complex neonatal congenital heart disease (CHD) and affects neurodevelopmental outcomes.
Reducing Perioperative Brain Injury in Congenital Heart Disease: A Ray of Hope
Jane W. Newburger, MD, MPH
doi : 10.1016/j.jacc.2022.11.027
Volume 81, Issue 3, 24 January 2023, Pages 267-269
Albuminuria and Heart Failure: JACC State-of-the-Art Review
Muhammad Shahzeb Khan, MD, MSC ,a Izza Shahid, MBBS,b Stefan D. Anker, MD, PHD, c Gregg C. Fonarow, MD,d Marat Fudim, MD, MHS,a,e Michael E. Hall, MD, MHS, f Adrian Hernandez, MD, MHS, a,e Alanna A. Morris, MD,g Tariq Shafi, MD, MHS, h Matthew R. Weir, MD,i Faiez Zannad, MD, PHD, j George L. Bakris, MD, k Javed Butler, MD, MPH, MBA
doi : 10.1016/j.jacc.2022.10.028
Volume 81, Issue 3, 24 January 2023, Pages 270-282
Although chronic kidney disease is characterized by low glomerular filtration rate (GFR) or albuminuria, estimated GFR (eGFR) is more widely utilized as a marker of risk profile in cardiovascular diseases, including heart failure (HF).
High-Risk Pulmonary Embolism During Labor: JACC Patient Care Pathways
Hooman Poor, MD,a Gregory Serrao, MD,b Julia Grapsa, MD, PHD, c Y.S. Chandrashekhar, MD,d Angela Bianco, MD, e Robert A. Lookstein, MD,f Valentin Fuster, MD, PH D
doi : 10.1016/j.jacc.2022.10.004
Volume 81, Issue 3, 24 January 2023, Pages 283-291
While in labor, a 37-year-old woman developed acute dyspnea, hypoxemia, and tachycardia.
2022 ACC Expert Consensus Decision Pathway for Integrating Atherosclerotic Cardiovascular Disease and Multimorbidity Treatment: A Framework for Pragmatic, Patient-Centered Care: A Report of the American College of Cardiology Solution Set Oversight Committee
doi : 10.1016/j.jacc.2022.08.754
Volume 81, Issue 3, 24 January 2023, Pages 292-317
Cardiopulmonary Exercise Testing in Children After Recovery From Multisystem Inflammatory Syndrome
Nicholas J. Robles, MD Todd T. Nowlen, MD Arash A. Sabati, MD
doi : 10.1016/j.jacc.2022.10.031
Volume 81, Issue 3, 24 January 2023, Pages 318-319
Outcomes in Bicuspid Aortic Valve Disease
Ramdas G. Pai, MD
doi : 10.1016/j.jacc.2022.10.032
Volume 81, Issue 3, 24 January 2023, Page e23
Reply: Outcomes in Bicuspid Aortic Valve Disease
Sébastien Hecht, MSc Jeroen J. Bax, MD, PhD *Philippe Pibarot, DVM, PhD
doi : 10.1016/j.jacc.2022.11.019
Volume 81, Issue 3, 24 January 2023, Page e25
